{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T19:59:43Z","timestamp":1773777583455,"version":"3.50.1"},"reference-count":185,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[1999,10]]},"DOI":"10.1016\/s0196-9781(99)00130-8","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T15:29:43Z","timestamp":1027610983000},"page":"1247-1262","source":"Crossref","is-referenced-by-count":167,"title":["Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis\u2606"],"prefix":"10.1016","volume":"20","author":[{"given":"Andrew V","family":"Schally","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0196-9781(99)00130-8_BIB1","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1200\/JCO.1987.5.6.912","article-title":"Zoladex. A sustained-release monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer","volume":"5","author":"Ahmann","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0015-0282(97)81407-0","article-title":"Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation","volume":"67","author":"Albano","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/09513598809107655","article-title":"Induction of ovulation with [d-Trp6]LHRH combined with purified FSH in patients with polycystic ovarian disease","volume":"2","author":"Ayalon","year":"1988","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0006-291X(71)90623-1","article-title":"Structure of the porcine LH- and FSH-releasing hormone. II. Confirmation of the proposed structure by conventional sequential analysis","volume":"44","author":"Baba","year":"1971","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1399-3011.1988.tb01373.x","article-title":"New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogs","volume":"32","author":"Bajusz","year":"1988","journal-title":"Int J Peptide Prot Res"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB6","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1073\/pnas.86.16.6318","article-title":"Highly potent analogs of luteinizing hormone-releasing hormone containing d-phenylalanine nitrogen mustard in position 6","volume":"86","author":"Bajusz","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.1994.tb02475.x","article-title":"Sustained suppression of serum LH, FSH and testosterone and increase of high-density lipoprotein cholesterol by daily injections of the GnRH antagonist cetrorelix over 8 days in normal men","volume":"40","author":"Behre","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/jc.75.2.393","article-title":"Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist Cetrorelix (SB-75) in normal men","volume":"75","author":"Behre","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB9","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1210\/jc.82.5.1403","article-title":"High loading and low maintenance doses of a gonadotropin-releasing hormone antagonist effectively suppress serum luteinizing hormone, follicle-stimulating hormone, and testosterone in normal men","volume":"82","author":"Behre","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/jc.74.1.84","article-title":"Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception","volume":"74","author":"Behre","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1126\/science.100883","article-title":"Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone","volume":"202","author":"Belchetz","year":"1978","journal-title":"Science"},{"issue":"Suppl 6","key":"10.1016\/S0196-9781(99)00130-8_BIB12","first-page":"9","article-title":"National Cancer Institute study of luteinizing hormone-releasing hormone plus flutamide versus luteinizing hormone-releasing hormone plus placebo","volume":"18","author":"Benson","year":"1991","journal-title":"Semin Oncol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(79)90235-6","article-title":"Intranasal gonadotrophin-releasing hormone agonist as a contraceptive agent","volume":"2","author":"Bergquist","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/jcem-60-5-998","article-title":"Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen","volume":"60","author":"Bhasin","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB15","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/0002-9378(89)90669-8","article-title":"Treatment of advanced refectory ovarian carcinoma with a gonadotropin-releasing hormone analogue","volume":"161","author":"Bruckner","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1073\/pnas.69.1.278","article-title":"Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF)","volume":"69","author":"Burgus","year":"1972","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB17","first-page":"190","article-title":"Suppressive effect of an inhibitory LHRH analog on the gonadotropin response to LHRH in normal women","volume":"25","author":"Canales","year":"1980","journal-title":"Int J Fertil"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1210\/jcem-56-5-897","article-title":"Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist","volume":"56","author":"Chang","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB19","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1210\/jc.83.11.3826","article-title":"Efficacy and safety of luteinizing hormone-releasing hormone antagonist Cetrorelix in the treatment of symptomatic benign prostatic hyperplasia","volume":"83","author":"Comaru\u2013Schally","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB20","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1210\/jcem-59-5-888","article-title":"Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty","volume":"58","author":"Comite","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1056\/NEJM199101103240205","article-title":"Gonadotropin-releasing hormone and its analogs","volume":"324","author":"Conn","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB22","unstructured":"Corbin A, Beattie CW, Tracy J, Jones R, Foell TJ, Yardley J, Rees RWA. The anti-reproductive pharmacology of LHRH and the antagonistic analogs. Int J Fertil 1976:81\u201392."},{"key":"10.1016\/S0196-9781(99)00130-8_BIB23","first-page":"290","article-title":"Long-acting agonists of LH-RH in the treatment of large ovarian endometriomas","volume":"32","author":"Cortes\u2013Prieto","year":"1987","journal-title":"Int J Fertil"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1021\/jm00225a018","article-title":"Analogs of luteinizing hormone-releasing hormone with increased biological activity produced by d-amino acid substitutions in position 6","volume":"19","author":"Coy","year":"1976","journal-title":"J Med Chem"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB25","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/cncr.1990.66.s5.1035","article-title":"Hormonal therapy of prostatic carcinoma. Defining the challenge","volume":"66","author":"Crawford","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJM198908173210702","article-title":"A controlled trial of leuprolide with and without flutamide in prostatic carcinoma","volume":"321","author":"Crawford","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1210\/jcem-52-2-370","article-title":"Therapeutic use of pituitary desensitization with a long-acting LHRH agonist","volume":"52","author":"Crowley","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB28","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/oxfordjournals.humrep.a138597","article-title":"Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation","volume":"9","author":"Diedrich","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB29","first-page":"4091","article-title":"Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145","volume":"54","author":"Dondi","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/jc.78.2.343","article-title":"Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period","volume":"78","author":"Dubourdieu","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB31","first-page":"43","article-title":"Luteinizing hormone-releasing hormone (LHRH) agonists","volume":"13","author":"Dutta","year":"1988","journal-title":"Drugs Future"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB32","first-page":"761","article-title":"Luteinizing hormone-releasing hormone (LHRH) antagonists","volume":"13","author":"Dutta","year":"1988","journal-title":"Drugs Future"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/jcem-64-3-425","article-title":"Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists","volume":"64","author":"Eidne","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0960-0760(97)00189-1","article-title":"Effects of LHRH-analogs on mitogenic signal transduction in cancer cells","volume":"65","author":"Emons","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB35","first-page":"5439","article-title":"High affinity binding and direct antiproliferative effects of LH-RH analogs in human ovarian cancer cell lines","volume":"53","author":"Emons","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1043-2760(97)00155-0","article-title":"Growth-inhibitory actions of analogs of luteinizing hormone releasing hormone on tumor cells","volume":"8","author":"Emons","year":"1997","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB37","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1452::AID-CNCR12>3.0.CO;2-Z","article-title":"Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer - A prospective double-blind randomized trial","volume":"78","author":"Emons","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0277-5379(89)90011-4","article-title":"Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata","volume":"25","author":"Emons","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB39","first-page":"1364","article-title":"The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers","volume":"9","author":"Emons","year":"1994","journal-title":"Reproduction"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB40","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1210\/jc.77.6.1458","article-title":"High affinity binding and direct antiproliferative effects of LH-RH analogs in human endometrial cancer cell lines","volume":"77","author":"Emons","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jcla.1860030302","article-title":"Characteristics and distribution of receptors for [d-Trp6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor and sex steroids in 500 biopsy samples of human breast cancer","volume":"3","author":"Fekete","year":"1989","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB42","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/humrep\/13.6.1660","article-title":"Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix","volume":"13","author":"Felberbaum","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB43","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/0002-9378(90)91438-I","article-title":"Polycystic ovary syndrome","volume":"163","author":"Filicori","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB44","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/0002-9378(83)90463-5","article-title":"A conservative approach to the management of uterine leiomyomas","volume":"147","author":"Filicori","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00006676-199209000-00002","article-title":"Treatment of duct carcinoma of the pancreas with the LH-RH analogue Buserelin","volume":"7","author":"Friess","year":"1992","journal-title":"Pancreas"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB46","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0006-291X(74)90830-4","article-title":"Synthetic analogs of luteinizing hormone-releasing hormone (LHRH) substituted in positions 6 and 10","volume":"57","author":"Fujino","year":"1974","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB47","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1210\/jcem-64-6-1331","article-title":"Effect of a GnRH analogue (leuprolide) on benign prostatic hypertrophy","volume":"64","author":"Gabrilove","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB48","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1471-0528.1991.tb15343.x","article-title":"A new treatment for endometrial cancer with gonadotropin-releasing hormone analogue","volume":"98","author":"Gallagher","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB49","first-page":"19","article-title":"Long-term use of an LH-RH agonist in the management of uterine leiomyomas","volume":"34","author":"George","year":"1989","journal-title":"Int J Fertil"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB50","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/humrep\/12.9.2028","article-title":"Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix","volume":"12","author":"Gonzalez\u2013Barcena","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0753-3322(89)90014-0","article-title":"Influence of d-Trp6-LH-RH on the survival time in patients with advanced pancreatic cancer","volume":"43","author":"Gonzalez\u2013Barcena","year":"1989","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB52","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0140-6736(77)92893-8","article-title":"Suppression of gonadotropin release in man by an inhibitory analogue of luteinizing hormone-releasing hormone","volume":"2","author":"Gonzalez\u2013Barcena","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB53","series-title":"Treatment with GnRH Analogs","first-page":"139","article-title":"Treatment of patients with advanced prostate cancer with LH-RH antagonist Cetrorelix","author":"Gonzalez\u2013Barcena","year":"1996"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB54","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0090-4295(95)80018-2","article-title":"Luteinizing hormone-releasing hormone antagonist SB-75 (Cetrorelix) as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord","volume":"45","author":"Gonzalez\u2013Barcena","year":"1995","journal-title":"Urology"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB55","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1530\/eje.0.1310286","article-title":"Inhibition of luteinizing hormone, follicle-stimulating hormone and sex-steroid levels in men and women with a potent antagonist analog of luteinizing hormone-releasing hormone, Cetrorelix (SB-75)","volume":"131","author":"Gonzalez\u2013Barcena","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB56","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/pros.2990240206","article-title":"Responses to the antagonistic analog of LH-RH (SB-75, Cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer","volume":"24","author":"Gonzalez\u2013Barcena","year":"1994","journal-title":"Prostate"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0010-7824(84)90094-5","article-title":"Inhibition of ovulation by intranasal Nafarelin, a new superactive agonist GnRH","volume":"30","author":"Gudmundsson","year":"1984","journal-title":"Contraception"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB58","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0015-0282(16)57986-2","article-title":"Flare-up of endometriosis induced by gonadotropin-releasing hormone agonist leading to bowel obstruction","volume":"64","author":"Hall","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB59","doi-asserted-by":"crossref","unstructured":"Halmos G, Arencibia JM, Schally AV, Davis R, Bostwick DG. High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers. J Urol 1999 (in press).","DOI":"10.1097\/00005392-200002000-00062"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3835(98)00316-4","article-title":"Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high-affinity to human breast cancers","volume":"136","author":"Halmos","year":"1999","journal-title":"Cancer Lett"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB61","first-page":"255","article-title":"Pernasal gonadorelin (GNRH) analog therapy in a boy with early puberty","volume":"5","author":"Happ","year":"1981","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB62","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1210\/jc.83.7.2343","article-title":"Use of a gonadotropin-releasing hormone antagonist as a physiologic probe of polycystic ovary syndrome","volume":"83","author":"Hayes","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB63","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/bmj.289.6454.1267","article-title":"Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist","volume":"289","author":"Healy","year":"1984","journal-title":"Br Med J"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB64","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1126\/science.6773142","article-title":"Male contraception","volume":"209","author":"Heber","year":"1980","journal-title":"Science"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB65","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198802253180805","article-title":"Administration of nasal Nafarelin as compared with oral danazol for endometriosis","volume":"318","author":"Henzl","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB66","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1210\/jc.77.4.963","article-title":"Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factor","volume":"77","author":"Hershkovitz","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB67","first-page":"817","article-title":"Expression of the messenger ribonucleic acids for luteinizing hormone-releasing hormone and its receptor in human ovarian epithelial carcinoma","volume":"55","author":"Irmer","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB68","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1210\/jc.79.3.916","article-title":"Expression of luteinizing hormone-releasing hormone and its mRNA in human endometrial cancer cell lines","volume":"79","author":"Irmer","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB69","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/humrep\/13.2.294","article-title":"First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462)","volume":"13","author":"Itskovitz\u2013Eldor","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB70","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1021\/jm970024p","article-title":"Betidamino acid scan of the GnRH antagonist Acyline","volume":"40","author":"Jiang","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB71","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0015-0282(16)41963-1","article-title":"Delay of puberty and inhibition of reproductive processes in the rat by a gonadotropin-releasing hormone agonist analog","volume":"27","author":"Johnson","year":"1976","journal-title":"Fertil Steril"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB72","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1097-0045(19970801)32:3<164::AID-PROS2>3.0.CO;2-L","article-title":"LH-RH antagonist Cetrorelix (SB-75), and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice","volume":"32","author":"Jungwirth","year":"1987","journal-title":"Prostate"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB73","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0959-8049(97)00072-5","article-title":"Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by LH-RH antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II","volume":"33","author":"Jungwirth","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB74","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<909::AID-CNCR16>3.0.CO;2-4","article-title":"Inhibition of growth of CAKI-I human renal adenocarcinoma in vivo by LH-RH antagonist Cetrorelix, somatostatin analog RC-160 and bombesin antagonist RC-3940-II","volume":"82","author":"Jungwirth","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB75","first-page":"877","article-title":"Regression of rat Dunning R-3327-H prostate carcinoma by treatment with targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 containing 2-pyrrolinodoxorubicin","volume":"10","author":"Jungwirth","year":"1997","journal-title":"Int J Oncol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB76","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2608::AID-CNCR17>3.0.CO;2-H","article-title":"Complete regression of MX-1 human breast cancer xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207","volume":"85","author":"Kah\u00e1n","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB77","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1530\/eje.0.1370183","article-title":"Molecular structure of the human gonadotropin-releasing hormone receptor gene","volume":"137","author":"Kakar","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB78","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0303-7207(94)90196-1","article-title":"The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary","volume":"106","author":"Kakar","year":"1994","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB79","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1210\/jcem-69-5-1087","article-title":"Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (Leuprolide acetate, Lupron depot) in children with precocious puberty","volume":"69","author":"Kappy","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB80","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1210\/edrv-7-1-44","article-title":"Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists","volume":"7","author":"Karten","year":"1986","journal-title":"Endocr Rev"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB81","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1210\/jcem-29-8-1046","article-title":"Stimulation of LH release in men and women by hypothalamic LH-releasing hormone purified from porcine hypothalami","volume":"29","author":"Kastin","year":"1969","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB82","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0002-9378(70)90293-0","article-title":"Administration of LH-releasing hormone to selected human subjects","volume":"108","author":"Kastin","year":"1970","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB83","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1200\/JCO.1989.7.8.1113","article-title":"The German Zoladex trial group","volume":"7","author":"Kaufmann","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB84","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2265.1984.tb03433.x","article-title":"Treatment of precocious puberty with LH-RH analogue in combination with cyproterone acetate\u2014further experience","volume":"20","author":"Kauli","year":"1984","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB85","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0015-0282(16)56214-1","article-title":"Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist","volume":"60","author":"Kettel","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB86","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0167-0115(93)90338-9","article-title":"Regulation of endometrial cancer cell growth by insulin-like growth factors and luteinizing hormone-releasing hormone antagonist SB-75","volume":"48","author":"Kleinman","year":"1993","journal-title":"Reg Pept"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB87","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(82)92339-X","article-title":"Treatment with a luteinizing hormone-releasing hormone analogue (Buserelin) in premenopausal patients with metastatic breast cancer","volume":"1","author":"Klijn","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/acta.0.1280015","article-title":"Hormonal responses to the new potent GnRH antagonist Cetrorelix","volume":"128","author":"Klingmuller","year":"1993","journal-title":"Acta Endocrinol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB89","first-page":"53","article-title":"The neuroendocrine control of the menstrual cycle","volume":"36","author":"Knobil","year":"1980","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB90","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1097-0045(19990201)38:2<151::AID-PROS9>3.0.CO;2-#","article-title":"Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice","volume":"38","author":"Kopp\u00e1n","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB91","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1073\/pnas.88.3.844","article-title":"Inhibition of growth of experimental prostate cancer with sustained delivery systems (microcapsules and microgranules) of the luteinizing hormone-releasing hormone antagonist SB-75","volume":"88","author":"Korkut","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB92","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1056\/NEJM198908173210701","article-title":"Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide)","volume":"321","author":"Kuhn","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB93","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0022-5347(17)43380-5","article-title":"Flutamide eliminates the risk of disease flare in prostatic cancer patients treated with a luteinizing hormone-releasing hormone agonist","volume":"138","author":"Labrie","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB94","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-65-5-946","article-title":"Gonadotropin and \u03b1-subunit secretion during long term pituitary suppression by d-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty","volume":"65","author":"Lahlou","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB95","first-page":"429","article-title":"Decrease in the level and mRNA expression of LH-RH and EGF receptors after treatment with LH-RH antagonist Cetrorelix in DU-145 prostate tumor xenografts in nude mice","volume":"13","author":"Lamharzi","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB96","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0167-0115(98)00119-0","article-title":"Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors","volume":"77","author":"Lamharzi","year":"1998","journal-title":"Reg Pept"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB97","doi-asserted-by":"crossref","first-page":"8864","DOI":"10.1073\/pnas.95.15.8864","article-title":"Growth hormone-releasing hormone antagonist MZ-5\u2013156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II tumors","volume":"95","author":"Lamharzi","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB98","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0015-0282(16)46522-2","article-title":"Potential new treatment of endometriosis","volume":"38","author":"Lemay","year":"1982","journal-title":"Fertil Steril"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB99","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0015-0282(16)56932-5","article-title":"A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge","volume":"62","author":"Leroy","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1210\/jc.75.1.207","article-title":"Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP","volume":"75","author":"Limonta","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB101","first-page":"1134","article-title":"Comments on inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II","volume":"34","author":"Limonta","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB102","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198109173051203","article-title":"Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal man","volume":"305","author":"Linde","year":"1981","journal-title":"N Eng J Med"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB103","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1073\/pnas.85.21.8236","article-title":"Antide and related antagonists of luteinizing hormone release with long action and oral activity","volume":"85","author":"Ljungqvist","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB104","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0015-0282(16)48152-5","article-title":"Regression of leiomyomata uteri following hypoestrogenism induced by repetitive LHRH agonist treatment","volume":"42","author":"Maheaux","year":"1984","journal-title":"Fertil Steril"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1210\/edrv-7-1-89","article-title":"Treatment of breast cancer with gonadotropin-releasing hormone","volume":"7","author":"Manni","year":"1986","journal-title":"Endocr Rev"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB106","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/jcem-66-1-3","article-title":"Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty","volume":"66","author":"Mansfield","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB107","series-title":"Hormonal Manipulation of Cancer","first-page":"315","article-title":"LHRH agonist","author":"Math\u00e9","year":"1987"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB108","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/pros.2990090404","article-title":"Phase II Trial with d-Trp-6-LH-RH in prostatic carcinoma","volume":"9","author":"Math\u00e9","year":"1986","journal-title":"Prostate"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB109","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0006-291X(71)90491-8","article-title":"Synthesis of the porcine LH- and FSH-releasing hormone by the solid-phase method","volume":"45","author":"Matsuo","year":"1971","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB110","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0006-291X(71)80019-0","article-title":"Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence","volume":"43","author":"Matsuo","year":"1971","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB111","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jcem-54-5-1081","article-title":"Medical oophorectomy using a long-acting GnRH agonist","volume":"54","author":"Meldrum","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB112","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/313231a0","article-title":"Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist","volume":"313","author":"Miller","year":"1985","journal-title":"Nature"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB113","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/jnci\/89.23.1803","article-title":"Growth inhibition of human ovarian cancers by cytotoxic analogs of luteinizing hormone-releasing hormone","volume":"89","author":"Miyazaki","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB114","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0002-9378(99)70600-9","article-title":"Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice","volume":"180","author":"Miyazaki","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB115","first-page":"265","article-title":"Suppression of plasma gonadotropins by Abarelix","volume":"2","author":"Molineaux","year":"1998","journal-title":"Mol Urol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB116","first-page":"508","article-title":"Synth\u00e8se totale par phase solide d\u2019un d\u00e9capeptide qui stimule la s\u00e9cr\u00e9tion des gonadotropines hypophysaires LH et FSH","volume":"273","author":"Monahan","year":"1971","journal-title":"C R Acad Sci Paris"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB117","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0002-9378(91)90680-P","article-title":"Fibrocystic disease of the breast in premenopausal women","volume":"164","author":"Monsonego","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB118","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1073\/pnas.93.14.7269","article-title":"Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent","volume":"93","author":"Nagy","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB119","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1210\/edrv-11-2-326","article-title":"Signal transduction mechanism of Ca2+ mobilizing hormones","volume":"11","author":"Naor","year":"1990","journal-title":"Endocr Rev"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB120","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0015-0282(16)57531-1","article-title":"Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix)","volume":"63","author":"Nelson","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB121","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0010-7824(78)80005-5","article-title":"Inhibition of ovulation in women by chronic treatment with a stimulatory LHRH analogue\u2014a new approach to birth control?","volume":"17","author":"Nillius","year":"1978","journal-title":"Contraception"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB122","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(16)56933-7","article-title":"The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program","volume":"62","author":"Olivenness","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB123","first-page":"1382","article-title":"Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day eight of in vitro fertilization cycles","volume":"10","author":"Olivenness","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB124","first-page":"1202","article-title":"Randomised controlled study of orchidectomy vs long-acting d-Trp-6-LHRH microcapsules in advanced prostatic carcinoma","volume":"2","author":"Parmar","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB125","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/bmj.296.6631.1229","article-title":"Response to [d-Trp6]LHRH (Decapeptyl) microcapsules in advanced ovarian cancer","volume":"296","author":"Parmar","year":"1988","journal-title":"Br Med J"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB126","first-page":"531","article-title":"Therapy of advanced ovarian cancer with d-Trp6-LH-RH (Decapeptyl) microcapsules","volume":"42","author":"Parmar","year":"1988","journal-title":"Biomed Pharmacother"},{"issue":"Suppl","key":"10.1016\/S0196-9781(99)00130-8_BIB127","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0090-4295(89)90106-4","article-title":"Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma","volume":"33","author":"Peeling","year":"1989","journal-title":"Urology"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB128","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0015-0282(16)59403-5","article-title":"Treatment of leiomyomata uteri with d-Trp6-LHRH","volume":"48","author":"Perl","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB129","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM198709033171004","article-title":"The effect of nafarelin acetate, a luteinizing hormone-releasing hormone agonist, on benign prostatic hyperplasia","volume":"317","author":"Peters","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB130","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1210\/en.137.8.3430","article-title":"Chronic administration of luteinizing hormone-releasing hormone (LHRH) antagonist Cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats","volume":"137","author":"Pinski","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB131","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/bjc.1986.260","article-title":"Remission of postmenopausal breast cancer during treatment with the luteinizing hormone releasing hormone agonist ICI 118630","volume":"54","author":"Plowman","year":"1986","journal-title":"Br J Cancer"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB132","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0140-6736(84)92840-X","article-title":"Induction of ovulation of in vitro fertilization using Buserelin and gonadotropins","volume":"2","author":"Porter","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB133","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0167-0115(95)00014-3","article-title":"Primary structure of solitary form of gonadotropin-releasing hormone (GnRH) in cichlid pituitary","volume":"57","author":"Powell","year":"1995","journal-title":"Regul Pept"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB134","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/bjc.1990.236","article-title":"The effect of gonadotrophin releasing hormone analogs in prostate cancer are mediated through specific tumour receptors","volume":"62","author":"Qayum","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB135","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1073\/pnas.78.10.6509","article-title":"Inhibition of prostate tumour growth in two rat models by chronic administration of d-Trp6-LH-RH","volume":"78","author":"Redding","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB136","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1073\/pnas.80.5.1459","article-title":"Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone","volume":"80","author":"Redding","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB137","first-page":"2538","article-title":"Sustained-release formulations of LH-RH antagonist SB-75 inhibit proliferation and enhance the apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice","volume":"52","author":"Redding","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB138","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1073\/pnas.81.18.5845","article-title":"Long-acting delivery systems for peptide","volume":"81","author":"Redding","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB139","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1358\/dof.1994.019.03.238584","article-title":"Cetrorelix","volume":"19","author":"Reissmann","year":"1994","journal-title":"Drugs Future"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB140","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/oxfordjournals.humrep.a136219","article-title":"Development and applications of LHRH antagonists in the treatment of infertility\u2014an overview","volume":"10","author":"Reissmann","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB141","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1021\/jm00160a008","article-title":"New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro","volume":"29","author":"Rivier","year":"1986","journal-title":"J Med Chem"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB142","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0015-0282(16)43461-8","article-title":"Pituitary gonadotropins inhibition by a highly active analog of luteinizing hormone-releasing hormone","volume":"30","author":"Sandow","year":"1976","journal-title":"Fertil Steril"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB143","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/edrv-11-2-221","article-title":"Endocrine treatment of breast cancer in women","volume":"11","author":"Santen","year":"1990","journal-title":"Endocr Rev"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB144","series-title":"Advances in Gynecology and Obstetrics, General Gynecology, Vol 6","first-page":"3","article-title":"The use of LHRH analogs in gynecology and tumor therapy","author":"Schally","year":"1989"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB145","doi-asserted-by":"crossref","unstructured":"Schally AV. LH-RH analogs. I. Their impact on reproductive medicine. Gynecol Endocrinol 1999 (in press). Special Millenium Edition.","DOI":"10.3109\/09513599909167587"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB146","doi-asserted-by":"crossref","unstructured":"Schally AV, Arimura A, Baba Y, Nair RMG, Matsuo H, Redding TW, Debeljuk L, White WF. Purification and properties of the LH and FSH-releasing hormone from porcine hypothalami. Program of the 53rd Meeting of the Endocrine Society, San Francisco, California, June 24\u201326, 1971, Abstract #55.","DOI":"10.1016\/0006-291X(71)90766-2"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB147","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0006-291X(71)90766-2","article-title":"Isolation and properties of the FSH- and LH-releasing hormone","volume":"43","author":"Schally","year":"1971","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB148","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.173.4001.1036","article-title":"Gonadotropin-releasing hormone","volume":"173","author":"Schally","year":"1971","journal-title":"Science"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB149","series-title":"GnRH analogs in Cancer and in Human Reproduction. Basic Aspects, Vol. 1","first-page":"5","article-title":"Analogs of LHRH","author":"Schally","year":"1989"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB150","series-title":"Cancer Medicine, 4th Ed","first-page":"1067","article-title":"Hypothalamic and other peptide hormones. Chapter 71","author":"Schally","year":"1997"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB151","series-title":"Endometriosis Today","first-page":"401","article-title":"Antagonistic analogs of LHRH in oncology and gynecology","author":"Schally","year":"1997"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB152","first-page":"29","article-title":"Stimulation and inhibition of fertility through hypothalamic agents","volume":"1","author":"Schally","year":"1971","journal-title":"Drug Ther"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB153","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0015-0282(16)38580-6","article-title":"Hypothalamic FSH and LH-regulating hormone, structure, physiology, and clinical studies","volume":"22","author":"Schally","year":"1971","journal-title":"Fertil Steril"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB154","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0083-6729(08)60795-5","article-title":"FSH-releasing hormone and LH-releasing hormone","volume":"30","author":"Schally","year":"1972","journal-title":"Vitam Horm"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB155","first-page":"1","article-title":"Tyler Prize Oration\u2014LH-releasing hormone and its analogs","volume":"21","author":"Schally","year":"1976","journal-title":"Int J Fertil"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB156","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0015-0282(16)57752-8","article-title":"The privileges of a Nobel Laureate","volume":"64","author":"Schally","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1410001","article-title":"Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors","volume":"141","author":"Schally","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB158","series-title":"Treatment with GnRH Analogs","first-page":"33","article-title":"LH-RH analogs with cytotoxic radicals","author":"Schally","year":"1996"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB159","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1016\/S0021-9258(19)45877-8","article-title":"Isolation of the LH- and FSH-releasing hormone from porcine hypothalami","volume":"246","author":"Schally","year":"1971","journal-title":"J Biol Chem"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB160","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1073\/pnas.89.6.2336","article-title":"Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells","volume":"89","author":"Segal\u2013Abramson","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB161","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-5347(17)39868-3","article-title":"Leuprolide Study Group. Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer","volume":"143","author":"Sharifi","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB162","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1073\/pnas.86.5.1648","article-title":"Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone","volume":"86","author":"Sharoni","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB163","first-page":"1031","article-title":"Treatment with luteinizing hormone-releasing hormone antagonist SB-75 decreases levels of epidermal growth factor receptor and its mRNA in OV-1063 human epithelial ovarian cancer xenografts in nude mice","volume":"5","author":"Shirahige","year":"1994","journal-title":"Int J Oncol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB164","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0094-0143(21)00575-9","article-title":"Treatment of advanced prostate cancer","volume":"14","author":"Sogani","year":"1987","journal-title":"Urol Clin N Am"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB165","first-page":"489","article-title":"Presence and characteristics of receptors for [d-Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human ovarian cancer","volume":"12","author":"Srkalovic","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB166","first-page":"1841","article-title":"Detection and partial characterization of receptors for [d-Trp6]-LH-RH and EGF in human endometrial carcinoma","volume":"50","author":"Srkalovic","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB167","first-page":"161","article-title":"Expression and signal transduction pathways of gonadotropin releasing hormone receptors","volume":"30","author":"Stojilkovic","year":"1995","journal-title":"Rec Prog Horm Res"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB168","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1210\/jcem-61-1-142","article-title":"Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist","volume":"61","author":"Styne","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB169","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/82.6.513","article-title":"Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75","volume":"82","author":"Szende","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB170","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/1097-0142(19900515)65:10<2279::AID-CNCR2820651020>3.0.CO;2-3","article-title":"Inhibitory effects of analogs of luteinizing hormone-releasing hormone (LH-RH) and somatostatin on pancreatic cancers in hamsters","volume":"65","author":"Szende","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB171","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ijc.2910490220","article-title":"Effect of combination treatment with analogs of luteinizing hormone-releasing hormone (LH-RH) or somatostatin and 5-fluorouracil on pancreatic cancer in hamsters","volume":"49","author":"Szepeshazi","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB172","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/00001813-199711000-00009","article-title":"Targeted cytotoxic luteinizing hormone releasing hormone (LH-RH) analogs inhibit growth of estrogen-independent MXT mouse mammary cancer in vivo by decreasing cell proliferation and inducing apoptosis","volume":"8","author":"Szepeshazi","year":"1997","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB173","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1073\/pnas.79.5.1658","article-title":"Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing agonists","volume":"79","author":"Tolis","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB174","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/jc.75.2.476","article-title":"Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate","volume":"75","author":"Tom","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/oxfordjournals.humrep.a019409","article-title":"Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles","volume":"11","author":"Ubaldi","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB176","first-page":"45","article-title":"Rapid reduction of uterine myomas after short-term treatment with microencapsulated [d-Trp6]LHRH","volume":"2","author":"van Leusden","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB177","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/edrv-7-1-115","article-title":"Comparison of the potential for therapeutic utilities with gonadotrophin-releasing hormone agonists and antagonists","volume":"7","author":"Vickery","year":"1986","journal-title":"Endocr Rev"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB178","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1677\/joe.0.1110349","article-title":"Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist d-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer","volume":"111","author":"Walker","year":"1986","journal-title":"J Endocrinol"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB179","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.humrep.a136334","article-title":"Ovarian hyperstimulation for in vitro fertilization controlled by GnRH agonist administration in combination with human menopausal gonadotropins","volume":"1","author":"Wildt","year":"1986","journal-title":"Hum Reprod"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB180","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/bjc.1986.106","article-title":"The use of an LHRH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer","volume":"53","author":"Williams","year":"1986","journal-title":"Br J Cancer"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB181","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1073\/pnas.91.15.7090","article-title":"Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75","volume":"91","author":"Yano","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB182","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/1097-0142(19940215)73:4<1229::AID-CNCR2820730417>3.0.CO;2-1","article-title":"Inhibitory effect of bombesin\/gastrin-releasing peptide (GRP) antagonist RC-3095 and LH-RH antagonist SB-75 on growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice","volume":"73","author":"Yano","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB183","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0010-7824(81)90044-5","article-title":"Anovulatory effect of a LHRH antagonist in women","volume":"24","author":"Zarate","year":"1981","journal-title":"Contraception"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB184","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(87)91756-9","article-title":"Never on a Sunday","volume":"1","author":"Zorn","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/S0196-9781(99)00130-8_BIB185","first-page":"11","article-title":"Therapeutic hypogonadism induced by a delayed release preparation of microcapsules of d-Trp6-luteinizing hormone-releasing hormone","volume":"31","author":"Zorn","year":"1986","journal-title":"Int J Fertil"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978199001308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978199001308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T23:03:47Z","timestamp":1620428627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978199001308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10]]},"references-count":185,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1999,10]]}},"alternative-id":["S0196978199001308"],"URL":"https:\/\/doi.org\/10.1016\/s0196-9781(99)00130-8","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[1999,10]]}}}